Trade Summary

3 days ago, Goodrich Katherine, serving as Dir at Tarsus Pharmaceuticals, Inc. (TARS), sold 2,954 shares at $62.08 per share, for a total transaction value of $183,384.32. Following this transaction, Goodrich Katherine now holds 2,233 shares of TARS.

This sale represents a 56.95% decrease in Goodrich Katherine's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 4:17 PM ET, 2 days after the trade was made.

Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.